The Use of Expectancy and Empathy When Communicating With Patients With Advanced Breast Cancer; an Observational Study of Clinician-Patient Consultations by Vliet, L.M. van et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2019-09-17 and may be subject to
change.
1 July 2019 | Volume 10 | Article 464
ORIGINAL RESEARCH
doi: 10.3389/fpsyt.2019.00464
published: 17 July 2019
Frontiers in Psychiatry | www.frontiersin.org
Edited by: 
Paul Enck, 
University of Tübingen, Germany
Reviewed by: 
Johannes A. C. Laferton, 
University of Marburg, 
Germany 
Andreas Dinkel, 
Technical University of 
Munich, Germany
*Correspondence: 
Liesbeth van Vliet 
l.m.van.vliet@fsw.leidenuniv.nl
Specialty section: 
This article was submitted to 
Psychosomatic Medicine, 
a section of the journal 
Frontiers in Psychiatry
Received: 19 March 2019
Accepted: 12 June 2019
Published: 17 July 2019
Citation: 
van Vliet LM, Francke AL, 
Meijers MC, Westendorp J, 
Hoffstädt H, Evers AWM, 
van der Wall E, de Jong P, 
Peerdeman KJ, Stouthard J and 
van Dulmen S (2019) The Use of 
Expectancy and Empathy When 
Communicating With Patients 
With Advanced Breast Cancer; an 
Observational Study of Clinician–
Patient Consultations. 
Front. Psychiatry 10:464. 
doi: 10.3389/fpsyt.2019.00464
The Use of Expectancy and Empathy 
When Communicating With Patients 
With Advanced Breast Cancer; an 
Observational Study of Clinician–
Patient Consultations
Liesbeth Mirjam van Vliet 1,2,3*, Anneke L. Francke 2,4, Maartje C. Meijers 1,2, 
Janine Westendorp 2, Hinke Hoffstädt 2, Andrea W.M. Evers 1,3,5, Elsken van der Wall 6, 
Paul de Jong 7, Kaya J. Peerdeman 1,3, Jacqueline Stouthard 8 and Sandra van Dulmen 2,9,10
1 Health, Medical and Neuropsychology Unit, Institute of Psychology, Leiden University, Leiden, Netherlands, 2 Department 
of Communication, NIVEL, Netherlands Institute of Health Services Research, Utrecht, Netherlands, 3 Leiden Institute for 
Brain and Cognition (LIBC), Leiden University, Leiden, Netherlands, 4 Amsterdam Public Health Institute, Vrije Universiteit, 
Amsterdam, Netherlands, 5 Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands, 6 Department 
of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, 7 Department of Medical 
Oncology, St Antonius Hospital, Utrecht, Netherlands, 8 Department of Medical Oncology, Netherlands Cancer Institute, 
Amsterdam, Netherlands, 9 Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud 
University Medical Center, Nijmegen, Netherlands, 10 Faculty of Health and Social Sciences, University of South-Eastern 
Norway, Drammen, Norway
Background: Information provision about prognosis, treatments, and side-effects is 
important in advanced cancer, yet also associated with impaired patient well-being. To 
counter potential detrimental effects, communication strategies based on placebo and 
nocebo effect mechanisms might be promising to apply in daily practice. This study 
aimed to provide more insight into how often and how oncologists use expectancy and 
empathy expressions in consultations with patients with advanced breast cancer.
Methods: Forty-five consultations between oncologists and patients were audiotaped. To 
determine how often expectancy and empathy expressions were used, a coding scheme 
was created. Most consultations (n = 33) were coded and discussed by two coders, and 
the remaining 13 were coded by one coder. To determine how expectancy and empathy 
expressions were used, principles of inductive content analysis were followed.
Results: Discussed evaluation (i.e., scan) results were good (n = 26,58%) or uncertain 
(n = 12,27%) and less often bad (n = 7,15%). Uncertain expectations about prognosis, 
treatment outcomes, and side effects occurred in 13, 38, and 27 consultations (29%, 
85%, and 56%), followed by negative expectations in 8, 26, and 28 consultations (18%, 
58%, and 62%) and positive expectations in 6, 34, and 17 consultations (13%, 76%, 
and 38%). When oncologists provided expectancy expressions, they tapped into three 
different dimensions: relational, personal, and explicit. Positive expectations emphasized 
the doctor–patient relationship, while negative expectations focused on the severity of 
the illness, and uncertainty was characterized by a balance between (potential) negative 
outcomes and hope. Observed generic or specific empathy expressions were regularly 
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INTRODUCTION
When faced with a serious disease such as advanced breast cancer, 
patients need information to understand what is going on and to 
plan for their future (1). Information about prognosis, treatment 
outcomes and plans, and benefits and risks of treatments are 
essential to provide optimal patient-centered care. Earlier data 
showed that patients having experienced adequate information 
about treatment benefits and risks experienced better person-
centered care (2).
Despite its importance, information provision is by no means 
a “magic bullet” and also entails risks. There are several possible 
negative effects of information provision in advanced cancer. 
Explicit information about the incurability of a disease seems 
appreciated by most, but not all patients (3–5). Patients who are 
fully aware of their poor prognosis, are also the ones with the 
lowest reported quality of life and highest anxiety (6). It is known 
that providing information about side effects can increase their 
occurrence (7). A large study showed, for example, that breast 
cancer patients with relatively higher expectations of side effects are 
the ones experiencing the most side effects (8). While information 
provision is thus one of the cornerstones of communication (9), 
it can also lead to negative effects on patients’ well-being.
To counter any of these potential negative effects, 
communication strategies derived from placebo and nocebo 
mechanisms might be promising to apply in daily practice. 
Integrating the research worlds of communication and placebo 
effects is still in its infancy (10). Placebo effects can be seen as 
“all real biopsychological effects on patient outcomes that are 
not attributable to a medical-technical explanation” (11, 12). The 
most well-known mechanism via which placebo effects occur 
is the expectancy mechanism. There is ample evidence (mainly 
from experimental studies) that the use of positive expectations 
can influence clinical patients’ outcomes for the better (13, 14). 
For example, post-operative patients are known to experience 
less pain when pain medication is delivered in full view while 
verbally raising positive expectations about its effectiveness (15, 
16). A second possible placebo effect mechanism affecting patient 
outcomes is the empathy mechanism, which is only mentioned 
by few scholars so far (10, 17, 18). From communication studies, 
we know that empathy is highly appreciated by patients (3, 19). 
From experimental studies in advanced breast cancer, we know 
that physician empathy is capable of reducing patients’ emotional 
distress, while increasing information recall (4, 20, 21).
It is, however, unclear if and how expectancy and empathy 
strategies are currently employed by clinicians when discussing 
prognosis, treatment outcomes, and side effects with patients with 
advanced cancer. The aim of this study is to provide more insight 
into how often and how oncologists use expectancy and empathy 
expressions in consultations with patients with advanced breast 
cancer. This study serves as a starting point for a research area 
aimed at creating more insight into possible beneficial placebo 
and nocebo effect inspired communication strategies. Future 
studies should test the effect of specific communication strategies 
on patient outcomes, before the most beneficial strategies can be 
harnessed in clinical care.
METHODS
Design
We conducted a multi-center observational study of consultations 
between 12 oncologists and 45 patients with advanced breast 
cancer. Consultations were audiotaped, as audio observations 
provide more objective insights into communication behavior 
than self-reports. Data were collected between August and 
December 2018 at two Dutch city-based hospitals (one cancer-
specific hospital and one general hospital).
Ethical Approval
The study was evaluated by the Medical Ethical committee of the 
Netherlands Cancer Institute (NKI-AVL), which exempted the 
provided, most frequently understanding (n = 29,64% of consultations), respecting 
(n = 17,38%), supporting (n = 16,36%), and exploring (n = 16,36%). A lack of empathy 
occurred less often and contained, among others, not responding to patients’ emotional 
concerns (n = 13,27% of consultations), interrupting (n = 7,16%), and an absence of 
understanding (n = 4,9%).
Conclusion: In consultations with mainly positive or uncertain medical outcomes, 
oncologists predominantly made use of uncertain expectations (hope for the best, 
prepare for the worst) and used several empathic behaviors. Replication studies, e.g., in 
these and other medical situations, are needed. Follow-up studies should test the effect 
of specific communication strategies on patient outcomes, to counter potential negative 
effects of information provision. Studies should focus on uncertain situations. Ultimately, 
specific placebo and nocebo effect-inspired communication strategies can be harnessed 
in clinical care to improve patient outcomes.
Keywords: communication, placebo effects, nocebo effects, empathy, expectancy, cancer, palliative care, 
observational study
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study from formal ethical approval. Both participating hospitals 
approved the conduct of the study in their representative hospitals. 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki.
Sample
Initial consultations for patients with advanced breast cancer 
(i.e., the first time that patients would be informed that their 
disease is incurable) or follow-up visits in which evaluation 
results (i.e., scan results) would be discussed were included. 
It is likely that in these consultations, a detailed discussion of 
prognosis, treatment outcomes, and side effects would occur. 
The consultations had to include patients who were female, were 
≥18 years of age, had advanced cancer in the sense that cure was 
no option anymore (according to the medical team), were not 
in the terminal phase of their disease, were cognitively able to 
provide consent and to complete a questionnaire, and who had 
command of the Dutch language.
Recruitment
The medical team of the participating hospitals screened 
(mostly) weekly for eligible consultations and eligible patients. 
If there was too little time between identification of the 
consultation and the opportunity to recruit patients, eligible 
patients were not contacted. The remaining eligible patients 
were contacted by a member of the hospital team with a brief 
introduction of the study. The contact details of interested 
patients were transferred to the research team who explained 
the study in more detail via telephone contact with the eligible 
patient. More specifically, patients were informed that the 
study focused on communication between oncologists and 
patients, that one consultation would be audiotaped and that 
participants would have to complete both a pre-consultation 
question and a post-consultation questionnaire (only the post-
consultation questionnaire assessing patient characteristics is 
included in this article, as this was a descriptive study). The 
research team did not mention the advanced stage of the 
disease. Preliminary oral consent was provided via telephone, 
after which patients were sent a written information letter 
via post or e-mail, and written consent was gathered by the 
research team immediately pre-consultation in the waiting 
area of the hospital. It was stressed that participation was 
voluntary and that patients could always withdraw their 
participation. Participating oncologists also provided consent 
for the consultations to be audiotaped.
Sample Size
Being an audio-observation study of medical consultations 
(i.e., medical interviews) in which communication is explored 
in detail, data saturation was aimed for. Taken into account the 
variability in patients, oncologists, and consultations, we aimed 
for a somewhat larger sample of consultations than normally 
recommended (22) and aimed to include 35–40 consultations 
between patients and oncologists.
Outcomes
Background Characteristics: Participants 
and Consultations
Patients’ sociodemographic characteristics (e.g., age, ethnicity, 
education) and disease characteristics (i.e., treatments currently 
receiving) were assessed post-consultation using a self-created 
questionnaire.
Characteristics of the consultation were assessed by the coding 
team. This included consultation time and whether the provided 
evaluation results (i.e., scan results) in the consultations were 
“good” (e.g., regression or stable disease), “uncertain” (e.g., clinical 
data from scan results and blood results are contradictory), or 
“bad” (e.g., disease progression). These criteria were determined 
in collaboration with the practicing oncologists who were part 
of the research and authorship team (EW, PJ, and JS). The core 
coding team (LV, MM, JW, and HH) determined together the 
category of each result.
Coding
To determine the occurrence of expectancy and empathy 
expressions, we created a coding scheme. This coding scheme 
was based on previous studies in the field of communication and 
placebo and nocebo effect research [expectancy references (23–
28) and empathy references (4, 19–21, 29–35)], observations of 
other recorded consultations, and clinical and research expertise. 
See Table 1 for a more detailed overview and explanation of the 
coding scheme.
For the expectancy expressions, the coding scheme addressed 
the number and content of oncologist-expressed positive, 
negative, or uncertain expectations regarding i) prognosis, 
ii) treatment outcomes, iii) side effects, and iv) others. This 
latter category was created to ensure we would not miss any 
expectancy expressions that could not be captured in our 
predefined categories. We did, however, not encounter any “other 
expectancy expressions”; hence, this is not further discussed in 
the Results section.
For the empathy expressions, the coding scheme addressed 
the number and content of the following oncologist-expressed 
empathic behaviors (irrespective of patients’ expressed emotional 
expression, called “cue” or “concern”) (36): i) NURSE (Naming, 
Understanding, Respecting, Supporting, Exploring) (30, 31); 
ii) showing interest in the patient and her feelings, not just the 
disease (19); iii) not interrupting the patient (only “negative” 
was coded); and iv) other. We coded both the occurrence of 
an empathic behavior as well as a non-empathic behavior. We 
created a third response category in case patients provided an 
emotional expression, which was not picked up by oncologists, 
labeling this a “missed opportunity for empathy” (37).
Analyzing Process
The actual analyzing process consisted of several steps. We 
followed the Strengthening the Reporting of Observational Studies 
in Epidemiology (STROBE) Statement (38) and the Standards for 
Reporting Qualitative Research (SRQR) guideline (39), for the 
quantitative and qualitative part of the study, respectively.
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TABLE 1 | Coding scheme.
Codes and examples of expectancy-expressions
Code for each behavior how often it occurred and give the content (sentences) from which this became apparent. 
It is possible that an oncologist provided several remarks which e.g. illustrate that he/she is positive about the treatment outcomes. If that is the case, code each 
unique occurrence and provide the content for each occurrence. 
If there are two occurrences in one sentence, both are coded. 
Positive expectancy-expressions include expressions in which an oncologist expresses positive expectations about prognosis/treatment outcomes/side effects, 
negative expectancy-expressions include expressions in which an oncologists expresses negative expectations about prognosis/treatment outcomes/side effects, 
and neutral expectancy-expressions include expressions in which an oncologist expressed neither positive nor negative but neutral expectations about prognosis/
treatment outcomes/side effects.
Positive (number + content) Negative (number + content) Neutral (number + content)
Prognosis
(referring to life expectancy/
incurability)
“You are an active person, that will have 
a positive effect (on your life-expectancy, 
red)” (other taped consultation)
“You are not very fit anymore (talking 
about prognosis)” (other taped 
consultation)
“Your prognosis will also depend on 
your physical condition, how that will 
develop” (expert opinion)
Treatment outcomes
(referring to whether or not a 
treatment will work, and the 
possibility of (dis)continuation 
of treatment)
“I think this will work for you” (24) “The problem is that there is little 
medication that is our go-to, there is 
not much better I can offer you” (25, 26)
“It is like a lottery; for some patients the 
treatment will work, for others it won’t. 
That’s all I can say unfortunately” 
(expert opinion)
Side effects
(mentioned with reassurance 
→ positive
might or might not happen → 
neutral
mentioning side effect → 
negative)
“You should not believe all information 
on the internet. In my experience I 
have seen that around 80% of women 
respond very well with very little side 
effects” (expert opinion)
“You can also become much sicker 
because of the treatment” (other taped 
consultation)
“Fatigue can arise, but it might also not 
occur” (expert opinion)
Other
Codes and examples of empathy expressions
Code for each behavior how often it occurred and give the content (sentences) from which this became apparent.
It is possible that an oncologist provided several remarks that, e.g., showed an interest in a person. If that is the case, code each unique occurrence and provide the 
content for each occurrence.
If there are two occurrences in one sentence, both are coded.
For coding of the behaviors, it is not necessary that a patient expressed an explicit cue/concern. If a cue or concern was expressed, which was not responded upon 
by the oncologist, this is coded as “missed opportunity”.
Empathic behavior Yes + number/content No + number/content Missed opportunities
NURSE
a. Naming
(mentioning the occurring 
emotions explicitly)
“It sounds like you are worried” (30) “I can see you are sad, but let’s talk 





“I can’t imagine how difficult this news 
must be for you” (31)
“My experience is that most patients do 
not react to this news the way you do” 
(expert opinion)
c. Respecting
(giving a compliment about 
emotion/response patient)
“I am very impressed with how well 
you’ve continued to care for your 
children during this long illness” (30)
“I think your response is a bit 
exaggerated” (expert opinion)
d. Supporting
(stressing that a patient will 
be continuously cared for by 
oncologist/hospital)
“But whatever action we do take, 
and however that develops, we will 
continue to take good care of you. We 
will be with you all the way” (4)
“I will now refer you to the community 
care nurse. I will see you after the 
operation” (expert opinion)
e. Exploring
(exploring of further emotions)
“We’ve just discussed a lot. Tell me 
more about what you are feeling right 
now” (31)
“I don’t have any time left unfortunately. 
There are more patients waiting. I will 
ask a nurse to contact you” (expert 
opinion)
Showing interest in the patient and 
her feelings, not just the disease
“Would you appreciate it if I would 
speak to your children? With or 
without you, whatever you prefer” 
[expert opinion, based on (19)]
Not interrupting the patient
(only code in case of ‘no)
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Step 1: Patients’ background characteristics and consultations 
characteristics were analyzed using descriptive statistics.
Step 2: The consultations were coded to determine how often 
expectancy and empathy expressions were used by clinicians. All 
consultations were transcribed verbatim and personal identifiers 
were removed. First, the audiotapes of the consultations were 
listened to and the transcripts were read several times. Next, the 
abovementioned coding scheme (see Table 1) was applied and 
all specific positive/negative/uncertain expectancy expressions 
and empathic/non-empathic behaviors including the missed 
opportunities for empathy were copy-pasted from Word to 
a dedicated Excel template in which the specific behaviors 
were grouped together. In addition, how often all behaviors 
occurred per consultation was noted. Two investigators (MM 
and JW) independently coded 33 out of the 45 (73%) transcripts. 
All transcripts and coded segments were discussed and any 
discrepancies were resolved through discussion until a consensus 
was reached. The remaining 27% (n = 12) was coded by one 
investigator (JW). A third investigator (LV) coded all segments of 
a random 10% of the consultations (n = 4). Agreement between 
the investigators for all coded segments was 96.45% (136 out of 
141 segments). Descriptive statistics were used to describe how 
often all expectancy and empathy expressions occurred per 
consultation. To facilitate analyses, Stata 14.0 was used.
Step 3: The expectancy- and empathy-coded text segments 
were used to determine how oncologists use these behaviors 
in consultations. To do so, all the coded segments that were 
grouped together were explored following the principles of 
inductive content analysis (40). First, in the preparation phase, 
the text was read several times, and two researchers (LV and 
JW or HH) independently wrote a memo for each subset of 
coded behavior, with most remarkable outcomes and sub-
division of behaviors. These were discussed among the core 
researchers (LV, JW, MH, and MM). Next, in the organizing 
phase, text fragments belonging together were highlighted 
and codes were given. Emerging codes were grouped together 
under headings and compared to the entire dataset. In the 
final, reporting, phase, the final categories representing sub-
forms of specific behaviors were determined. One researcher 
systematically coded all text (LV, communication/psychology 
background), while interim results were discussed among 
the research team (with a psychology, nursing, sociology, 
medicine, and communication background) to prevent one-
sided interpretation of the data (41).
RESULTS
Participants
All approached oncologists participated (n = 12). A total of 84 
patients gave permission to be contacted by the research team. 
Of these, 19 gave no oral consent (they were not interested or 
found it too burdensome for the consultation to be audiotaped 
and/or to complete the questionnaires), 4 did not fulfill the 
inclusion criteria (e.g., they were scheduled for a check-up visit), 
2 could not be reached by telephone, 10 encountered logistical 
problems preventing participation (e.g., there were 2 patients at 
the same time, the oncologist was too busy, or the consultation 
was cancelled), and 4 gave preliminary oral consent but withdrew 
their consent later. Lastly, for 2 patients who provided written 
consent, the audio-recordings failed. Background characteristics 
of the remaining 45 consenting participants are displayed in 
Table 2.
Consultations
The consultation lasted, on average, 18.96  min (SD = 8.00; 
range = 4.43–34.83). All consultations were evaluative follow-up 
consultation in which evaluation results (i.e., scan results) were 
discussed. In 26 consultations (58%), good evaluation results 
were discussed; in 12 consultations (27%), uncertain evaluation 
results were discussed; and in 7 (15%), bad evaluation results were 
discussed. There were no disagreements within the coding theme 
when determining to which category a consultation belonged.








 Married 27 (66)
 Single (including divorced, widowed) 14 (34
Highest education1
 Low –
 Intermediate 1 9 (22)
 Intermediate 2 18 (44)
 High 14 (34)
Occupation
 Paid job 10 (24)
 Disabled/sick leave 14 (34)
 Housewife 4 (10)
 Retired 13 (32)
Ethnicity 
 Dutch 35 (86)
 Western immigrants 5 (12)
 Non-Western immigrant 1 (2)
Treatments currently receiving**
 Chemotherapy 18 (44)
 Radiotherapy 2 (5)
 Hormone therapy 16 (39)
 Immunotherapy 9 (22)
 Operation –
 Targeted therapy 4 (9)
 Symptom-oriented treatment 10 (24)
 Tumor-oriented treatment possible, but refrained from –
 Tumor-oriented treatment impossible 1 (2)
1Low = primary education or less.
Intermediate 1 = lower secondary.
Intermediate 2 = upper secondary.
High = tertiary.
*Out of the 45 participating women, 41 completed all questionnaires, data of the 
remaining 4 could not be retrieved.
**Women can receive several treatments, so this does not add up to 100%.
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Use of Expectancy Expressions
How Often Are Expectancy Expressions Used?
Positive Expectations
Positive expectations about prognosis were provided in 6 
(13%) consultations, followed by positive expectations about 
side effects, which occurred in 17 (38%) consultations, while 
in most consultations (n = 34, 76%), positive expectations 
about treatment outcomes were provided. On average, positive 
expectations about prognosis and side effects occurred less 
than once per consultation while positive expectations about 
treatment outcomes occurred more than twice per consultation 
(see Table 3).
Negative Expectations
Negative expectations about prognosis were provided in 8 (18%) 
consultations, followed by negative expectations about treatment 
outcomes, which occurred in 26 (58%) consultations, while 
in 28 (62%) consultations, negative expectations about side 
effects were provided. On average, negative expectations about 
prognosis occurred less than once while negative expectations 
about treatment outcomes and side effects occurred almost twice 
per consultation (see Table 3).
Uncertain Expectations
Uncertain expectations about prognosis were provided in 13 
(29%) consultations, followed by uncertain expectations about 
side effects, which occurred in 27 (56%) consultations, while in 
38 (84%) consultations, uncertain expectations about treatment 
outcomes were provided. On average, uncertain expectations 
about prognosis occurred less than once, while uncertain 
outcomes about treatment outcomes occurred more than four 
times per consultation (see Table 3).
How Are Expectancy Expressions Used
When oncologists employed expectancy expressions, they tapped 
into three different dimensions: i) relational, ii) personal, and iii) 
explicit. The relational dimension refers to the extent to which 
expectations enhance the oncologist–patient relationship. The 
personal dimension refers to the extent to which expectations 
incorporate a personal reflection from oncologists. The explicit 
dimension refers to the extent to which expectations are made 
explicit. The different dimensions occur to various degrees within 
positive, negative, and uncertain expectations.
Positive Expectations
Positive expectations were characterized by a high degree of—
explicit—reassurance and thereby an emphasis on the doctor–
patient relationship, while oncologists regularly referred to their 
personal thoughts and feelings. In Figure 1A, these different 
dimensions and their overlap are visually displayed. Patients 
were often reassured that there are still options available, that 
complaints are harmless, or that side effects will not be (or are 
TABLE 3 | The occurrence of expectancy expressions throughout the consultations.
Positive expectations Negative expectations Uncertain expectations 
n (%) M (SD)
range
Examples content n (%) M (SD)
range
Examples content n (%) M (SD)
range
Examples content
Prognosis 6 (13) 0.40 (1.25)
0–7
“Yes, but wait. For 
the time being, 
you’re still around”
8 (18) 0.40 (1.03)
0–4
“Um, well that makes 
that I don’t think 
your prospect is very 
positive”
13 (29) 0.8 (1.84)
0–8
“For how long this is 
going to go well? I 
hope for a terribly long 
time. Can I predict it 
fully? No I don’t know. 
Every time it’s for me 




34 (76) 2.58 (2.30)
0–10
“No, these numbers 
are not disturbing 
at all, those tumor 
markers. I sometimes 
see numbers of 
5,000 or 10,000”
26 (58) 1.78 (2.39)
0–11
“Um, well yes, that 
test result does scare 
me a bit, because … 
well, what you see on 
the scan is, well, that 
is not going well”
38 (84) 4.29 (4.27)
0–23
There’s always a 
possibility that it’ll 
work or a possibility 
that it won’t (…).: 
“And then you’re back 




17 (38) 0.80 (1.24)
0–4
“And we’re finding a 
better balance with 
the side-effects”
28 (62) 1.91 (2.37)
0–8)
“Because for 
tiredness I have no 
miracle cure.”
27 (56) 2.05 (2.84)
0–12
“And some people 
don’t experience this 
(side effect, red) at all 
and others a bit or very 
much (…) but there 
is no way to test that 
beforehand.”
n = number of consultation in which specific expectancy expression occurred.
(%) = percentage of consultations in which specific expectancy expression occurred.
M = mean number of specific expectancy expression per consultation.
SD = standard deviation of specific expectancy expression per consultation.
Range = Range of specific expectancy expression per consultation.
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not) too serious/burdensome. Such reassurance was frequently 
focused on very specific situations. Oncologists also regularly 
stressed their own thoughts and visions, which seemed to 
strengthen expressed positive expectations. Lastly, the doctor–
patient partnership was often emphasized by referring to “we”.
“I am not, I’m not worried about this at all. That scan is fine.”
“With that reduced dose that (irritated mucous membranes, 
ed). will also get better”
“And we’re finding a better balance with the side effects”
Example of a quote where the personal, relational, and explicit 
dimensions come together:
“Precisely, but just um looking into the far distance, I say 
yes, just carry on with it. Do we still have hormonal therapy 
as an alternative? Yes, if necessary we’ll use that. And if at a 
certain moment in time we are done with hormonal therapy, do 
we then still have something else? (…) Like chemo therapy? Yes. 
Even then there are some choices to be made and we’ll first and 
foremost have to make a choice that is then acceptable to you. 
(…) Do I have something good? Yes, I do. Is it acceptable to you? 
That is what we will talk about.”
Negative Expectations
Negative expectations were characterized by a high degree of 
personal reflections, which seemed to strengthen a more or 
less explicit negative future vision. In Figure 1B, these different 
dimensions and their overlap are visually displayed. Oncologists 
expressed their own worries, about disease progression, a lack 
of treatment effects or side effects by which they seemed to 
emphasize the severity of the situation.
“Do you want me to honestly tell you how um I think it’ll go? 
(…) Yes, I’m worried about you. Whether this will turn out well, 
because these blood counts, those blood platelets are suddenly 
so low.”
“Because for tiredness I have no miracle cure.”
Such negative expressions varied in their level of explicitness, 
with treatment-related expectations often being expressed 
more implicitly than side-effect-related expectations, and with 
prognostic-related expectations being expressed both explicitly 
and implicitly.
“For well, to be totally cured you have to, for that the various 
spots are actually too numerous.”
“When all is said and done, the options I have are not 
infinite. Then it’ll grow and then it’ll get into your system and 
still further.”
With negative expectations, there was much less emphasis 
on relationship building. In the rare occasions the relationship 
dimension was tapped into, oncologists seemed to either 
emphasize or de-emphasize the clinician–patient relationship:
“Yes, they are really nasty jabs. I have to admit that.”
FIGURE 1 | (A) Visual representation of the presence and overlap of the 
personal/relational/explicit dimensions of positive expectancy expressions. 
(B) Visual representation of the presence and overlap of the personal/
relational/explicit dimensions of positive expectancy expressions. (C) Visual 
representation of the presence and overlap of the personal/relational/explicit 
dimensions of positive expectancy expressions.
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Uncertain Expectations
Uncertain expectations were characterized by an emphasis 
on what an oncologist hopes for, but cannot guarantee. While 
expressing such hopes, oncologists both focused on their own 
perceptions, making it personal, and on the positive relationship 
with patients. In Figure 1C, these different dimensions and their 
overlap are visually displayed.
“For how long this is going to go well? I hope for a terribly 
long time. Can I predict it fully? No I don’t know. Every time it’s 
for me also a bit hoping that it’s OK.”
Most importantly, uncertain expectations seemed to represent 
a balancing act. On the one hand, patients were being prepared for 
negative outcomes such as a future discontinuation of treatments 
or occurrence of problematic side effects. On the other hand, 
potential possibilities were mentioned, which were not presented 
as “magic bullets” but as a quest for a balance between treatment 
(intensity) and side effects.
“So the first step is reducing the dose a bit and at a certain 
moment we’ll be putting in weeks of rest, with you doing two 
weeks followed by a week of no treatment. Um and doing so you 
hope that at a given time you’ll find a sort of stable situation 
that is doable for you, that you can get on with, doesn’t bother 
you too much yeah you’ll experience some bother, but something 
that you can get on with. If we should see that this causes 
problems, yeah well, then we’ll have to find the right balance, 
for that’s of course always what it is; the balance between side 
effect and effect.”
Uncertain expectations about current and future treatment 
options and side effects were predominantly implicit in nature, 
but also sometimes more explicit (especially regarding treatment 
outcomes). They focused on (the source of) side effects and 
complaints that are currently present or might develop in 
the future, but also on the continuation of current and future 
treatments.
“And some people don’t experience this (side effect, red) at 
all and others a bit or very much (…) but there is no way to test 
that beforehand.”
“There’s always a possibility that it’ll work or a possibility 
that it won’t.’ Patient: ‘Umm mm.’ Oncologist: ‘And then you’re 
back at the point of this uncertainty.”
Use of Empathy Expressions
Number of Expressions
Use of Empathy
All studied empathy expressions were displayed throughout the 
consultations, ranging from showing understanding of emotions 
in 29 (64%) consultations to the use of naming emotions in 4 
(9%) consultations. The other empathy expressions occurred in 
around a third of consultations, e.g., respecting (n = 17, 38%), 
supporting (n = 16, 36%), exploring of patients’ emotions (n = 
16, 36%), and showing interest in the patient (n = 13, 29%). On 
average, understanding remarks occurred more than twice per 
consultation, while all other statements occurred generally less 
than once per consultation (see Table 4).
Lack of Empathy
Non-empathic behaviors were infrequently displayed throughout 
the consultation; interrupting the patient occurred in 7 (16%) 
consultations, followed by 4 (9%) consultations in which a lack 
of understanding occurred, while showing non-supporting 
statements or a lack of interest in the patient occurred in 1 
consultation (2%). On average, negative behaviors occurred 
less than once per consultation (ranging from an average 
of 0.2 interruptions per consultation, to an average of 0.09 
lack of showing understanding towards patient emotions per 
consultation). However, in more than a quarter of consultations 
(n = 12, 27%), oncologists failed to pick up on an emotional 
expression from a patient, which occurred, on average, 0.89 
times per consultation (see Table 4).
How Empathy Expressions Are Used
Use of Empathy
When oncologists used empathy expressions, they used several 
manners to do so, which are closely aligned to the coding 
categories: NURSE (Naming, Understanding, Respecting, 
Supporting, Exploring) and showing interest in the person.
The most important distinction in empathy expressions 
referred to the level of specificity. Across the different NURSE 
categories, oncologists could either be generic in their level of 
expressed empathy, or, alternatively, could be specific. Specific 
empathic behaviors were characterized by referring to specific 
situations and emotions, or by referring to the individual.
Understanding generic: “Yes, I understand.”
Understanding specific: “Yeah, so it’s really stressful, isn’t it.”
Respecting generic: “OK, that’s very good” (responding to a 
patient saying she will walk the dog on the beach).
Respecting specific: “What an extraordinary person you 
are, aren’t you.”
Exploring generic: “For um, how um do you feel about it.”
Exploring specific: “And um … What do you find stressful 
about it? Is it such a result or is it the Nivolumab itself?”
When providing support, both generic and more specific 
statements were made that either referred to the oncologist 
proactively offering support, or referred to the patient proactively 
needing to request support.
Proactive oncologist generic: “Is there anything else I can 
do for you?”
Proactive oncologist specific: “You know what, I’ll give 
you a call tomorrow morning to see if things are getting a bit 
better.”
Proactive patient generic: “Oh, right. Or you can always 
give me a ring.”’
Proactive patient specific: “Um … hey, so give me a ring 
next week if you haven’t recovered from that flue yet.”
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Lastly, there were several ways in which oncologists showed 
an interest in the patient as a person. These included enquiring 
about holidays, patients’ loved ones, important days coming up, 
and non-cancer-related health problems.
“OK, nice where are you going?”
“And how many years have you been married for?”
Lack of Empathy
Although a lack of empathy did not frequently occur, there were 
a few occasions in which oncologists showed little understanding 
of patients’ emotions by talking or laughing over them.
Patient: “And um … well, that vocal cord, so you’re saying 
I’d better see the ENT doctor.” Oncologist: “We could also wait 
for a bit.”
Patient: “Right. Um … is the therapy we’re using now enough 
to extend my life?” Oncologist: “Oh what a difficult question ha 
ha [loud laughter].”
The one occasion in which there was little interest in the person 
occurred when an oncologist failed to enquire about an ill loved one.
Patient: “I’ll handle this again. Well, yes the oldest son has 
Pfeiffer disease, so … Oncologist: Yes, you mentioned that. Patient: 
So, yes that … Oncologist: Let’s look at the blood pressure.”
If patients were interrupted, this was mainly because 
oncologists seemed to complete their sentences.
Patient: “Right, so it’s not as if you spinal column as one….” 
Oncologist: “It’s counted spot by spot.”
TABLE 4 | The occurrence of empathy expressions throughout the consultations.
Empathic behavior Yes + number/content No + number/content
NURSE n (%) M (SD)
Range




(mentioning the occurring 
emotions explicitly)
4 (9) 0.09 (0.29)
0–1




29 (64) 2.27 (2.73)
0–13
“Yes, I understand” 4 (9) 0.09 (0.29)
0–1
Patient: “Right. Um … is the therapy 
we’re using now enough to extend 
my life?”
Oncologist: “Oh what a difficult 
question ha ha [loud laughter]” 
c. Respecting
(giving a compliment about 
emotion/response patient)
17 (38) 0.69 (1.08)
0–4
“Well I agree. I think you are handling 
this very very well”
– –
d. Supporting
(stressing that a patient will 
be continuously cared for by 
oncologist/hospital)
16 (36) 0.51 (1.01)
0–6
“Or you can always give me a ring” 1 (2) 0.02 (0.15)
0–1
“I think that is really something for a 
psychologist”
e. Exploring
(exploring of further emotions) 
16 (36) 0.47 (0.73)
0–3
Exploring specific: And um … What 
do you find stressful about it? Is it 
such a result or is it the Nivolumab 
itself? 
– –
Showing interest in the 
patient and her feelings, not 
just the disease 
13 (29) 0.62 (1.23)
0–6
“And how many years have you been 
married for?”
1 (2) 0.02 (0.15)
0–1
Patient: “I’ll handle this again. Well, 
yes the oldest son has Pfeiffer 
disease, so … Oncologist: Yes, you 
mentioned that. Patient: So, yes that 
… Oncologist: Let’s look at the blood 
pressure”
Not interrupting the patient
(only code in case of “no”)
7 (16) 0.2 (0.5)
0–2
Patient: “Right, so it’s not as if you 
spinal column as one…. “ Oncologist: 
“It’s counted spot by spot.” 
Missed opportunity
(only code in the case of 
occurrence, which is thus 
negative)
12 (27) 0.89 (2.36)
0–14
Patient: “Aaahhh liver biopsy really 
is hell. But OK you’re right I’m not a 
wimp, but I really don’t like that, but 
well.” Oncologist: “No, well, right.”
n = number of consultations in which specific empathy expression occurred.
(%) = percentage of consultations in which specific empathy expression occurred.
M = mean number of specific empathy expression per consultation.
(SD) = standard deviation of specific empathy expression per consultation.
Range = range of number of specific empathy expression per consultation.
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Lastly, oncologists sometimes did not respond to patients’ 
emotional expressions.
Patient: “Aaahhh liver biopsy really is hell. But OK you’re 
right I’m not a wimp, but I really don’t like that, but well.” 
Oncologist: “No, well, right.”
DISCUSSION
In this observational study of consultations between oncologists 
and patients with advanced breast cancer, we aimed to get an 
insight into and create a better understanding on how often and 
how oncologists make use of expectancy and empathy expressions 
in clinical care. While there has been a recent interest in the 
placebo and nocebo effects of communication, and clinicians’ 
empathic responses to patients’ expressed cues and concerns have 
extensively been studied (see, e.g., Zimmermann et al., 2007) (42), 
to the best of our knowledge, this is the first study to objectively 
determine how clinicians use expectancy and empathy expressions 
in advanced clinical breast cancer care. We found that in our sample, 
consisting of consultations in which mainly positive or uncertain 
medical outcomes were discussed, oncologists predominantly 
expressed uncertain expectations. Provided expectations differed 
in the extent to which they had a relational, personal, and explicit 
dimension. When expressing positive expectations, the doctor–
patient relationship was emphasized, negative expectations 
focused on the severity of the illness, and uncertain expectations 
were characterized by a balance between (potential) negative 
outcomes and hope. Moreover, oncologists displayed several 
generic and specific empathic behaviors, most frequently showing 
an understanding towards patients’ emotions. A lack of empathy 
was not common, but mainly included oncologists not responding 
to patients’ emotional expressions. In sum, although various 
placebo and nocebo effect-inspired communication strategies 
were observed, their generalizability and their effects on patient 
outcomes remain to be determined, especially in uncertain 
situations with inherent uncertain expectations.
Focusing on expectancy expressions, several of our results are 
noteworthy. First, most (n = 26, 58%) consultations contained 
a “good” medical outcome (i.e., scan results), but positive 
expectancy expressions did not occur more often than negative or 
uncertain expectations. It might be that oncologists in our sample 
were reluctant to express—overtly—positive expectations in the 
context of advanced cancer, as patients are known to already often 
hold unrealistic expectations about their disease and treatment 
aims (43–45). This contrasts results from a study among heart 
disease patients, in which clinicians were often overly positive 
(46). Indeed, oncologists place great importance on not offering 
false hopes (47). Although very understandable, by refraining 
from positive expectations, oncologists might miss out on the 
potential helpful effects of this communication strategy. Patients 
appreciate it when clinicians are optimistic (48) and stress what 
can be done when facing an incurable cancer diagnosis (3, 49). 
Moreover, outside of the area of (advanced) cancer, positive 
expectations have shown to influence patient outcomes such 
as pain (evaluations) [(14, 50) (van Vliet et al., submitted)] 
and symptom burden (48). While it is a prerequisite that such 
expectations are realistic in nature, our insights suggest that there 
might be an underused potential for stressing positive aspects 
when communicating with patients with advanced cancer.
A second important observation was that expectation 
expressions differed not only in content (positive, uncertain, and 
negative) but also in the dimensions of being relational, personal, 
and explicit. By reassuring patients of the positive nature of 
outcomes, or by stressing that they hope for positive outcomes, 
oncologists in our sample did not only provide information but 
also seem to build a relationship, two distinct core functions of 
medical consultations (9). The stressful nature of discussing bad 
news (50), such as a lack of further treatment options, might, for 
some oncologists, limit the ability for relationship-building when 
providing negative expectations. In these situations, the severity of 
the situation is emphasized by making use of the negative impact 
of self-referring (e.g., “I am worried”) in contrast to its optimistic 
impact when raising positive expectations (e.g., “I am not worried 
at all”). Interestingly, in a series of experimental studies aimed at 
helpful communication styles, all communication elements that 
led to positive effects made use of a personal account (e.g., “I 
understand you’re worried. We will look together at the options”) 
(4, 20, 21, 33) stressing the potential power of this dimension, 
also in the context of bad news. Lastly, the explicitness in 
which expectations were expressed varied widely, with more 
explicit expectations emphasizing an anticipation and implicit 
expectations characterizing uncertainty.
Uncertain situations seemed to be of critical importance and 
difficulty when raising expectations. In uncertain expectations, 
oncologists in our study made use of a balancing act in which 
they prepare patients for potential or certain negative outcomes, 
while simultaneously trying to offer some forms of perspective. 
In the literature, such an approach is called “Hope for the best, 
prepare for the worst” (51), illustrating a dual pathway followed 
in serious and uncertain illnesses. Previous studies have shown 
that patients differ in their preferences for how to handle the 
uncertainty of their advanced illness, with some wanting more 
explicit information than others (52). Clinicians, meanwhile, 
are reluctant towards and have difficulty in discussing clinician 
uncertainty (53, 54). We indeed found that the level of 
explicitness in particular varied widely when providing uncertain 
expectations, illustrating a lack of clear guidance on how to do 
so best. With treatment and care options in advanced cancer 
becoming increasingly complex, and targeted and personalized 
medicine options rapidly growing, there is a pressing need to 
develop more insight into how oncologists should best deal with 
uncertainty and provide expectations with an uncertain nature.
Focusing on empathy expressions, a more straightforward 
picture seemed to emerge compared to expectancy expressions. 
Oncologists made use of various forms of empathy, most 
frequently of showing understanding for patients’ emotions and 
complimenting patients on how they handle their disease. The 
importance of acknowledging the emotions of patients with 
advanced cancer has been stressed before (49). Noteworthy, 
empathic remarks varied widely in their level of specificity, e.g., 
“That’s good” compared to “You have handled situation X very 
well”. As patients value to be seen and treated as an individual 
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person (19), also when faced with an incurable cancer diagnoses 
(49), one could expect that more specific expressions of empathy 
are most appreciated and beneficial. Although intuitively logical, 
there is a lack of empirical evidence on the effect of more generic 
or specific empathic remarks.
Interestingly, while most patient complaints in medical care 
are about clinician communication, as well as in advanced 
illnesses [e.g., Refs. (55–57)], in our study, we found that a lack 
of empathic communication did not often occur. There were, 
however, occasions in which patients’ cues and concerns were 
not picked up by clinicians. Previous studies have shown that 
this is not uncommon in clinical practice (42, 58). If clinicians, 
however, do respond to emotional expressions, this can lead to 
positive outcomes, such as a decrease in consultation time (42), 
and an increase in the amount of information patients recall (58). 
Thus, based on our results, there seems to be room for improving 
the extent to which clinicians respond to patients’ emotional 
expressions, leading to potentially positive effects.
Limitations
Our study has limitations. Firstly, our participants might not be 
representative for the entire population of people with advanced 
breast cancer, as they were female, highly educated, almost 
completely with a Dutch or other Western European background, 
and mainly recruited in a specialized research-focused cancer 
hospital. Secondly, our analyses were based on transcripts and 
thus verbal communication, while non-verbal elements such as 
eye contact remained masked. Intonation was used in the first 
but not latter phases of the qualitative analyzing process, as we 
used the transcripts for the coding. Thirdly, as we focused on the 
communication within the 45 audiotaped consultations, we did 
not take into account the nested design of our study (expectancy 
and empathy expressions were clustered within consultations, 
which were clustered within oncologists, which were clustered 
within hospitals). The number of audiotaped consultations per 
oncologist ranged from 1 to 8, while 8 of the 12 participating 
oncologists were from the specialized hospital, implying that 
the communication from the oncologists with more audiotaped 
consultations and from the specialized hospital influenced our 
results more strongly. Fourthly, given our limited sample size, 
we did not explore differences in used manipulations between 
consultations with a good, bad, or uncertain medical outcome. 
Fifthly, we only included consultations in which test results were 
discussed as these were the only ones identified, which potentially 
limits the generalizability of our results to initial consultations. 
Sixthly, as the research area of the placebo effects of communication 
is still in development, we welcomed the comment of one of the 
reviewers who wondered whether a comment as “that scan is fine” 
is a positive expectation and hope future discussions will help to 
clarify the criteria under study. Seventhly, although we did not 
observe other categories of expectancy expressions apart from 
our predefined categories, we cannot rule out that this is due to 
an implicit bias of the coding team, who all had a background 
in communication research. Our conceptualization was further 
hampered by a lack of a universally agreed conceptualization of 
expectancies [see, e.g., Laferton et al. (59) for a detailed overview]. 
Eighthly, we did not assess what patients’ information and 
communication preferences were. Lastly, although all approached 
oncologists participated, they might form a subgroup of clinicians 
particularly interested and competent in communication.
Future Research
This study serves as a starting point for a research area aimed at 
creating more insight into possible beneficial placebo and nocebo 
effect-inspired communication strategies. The most pressing 
question our study does not answer is which specific forms of 
expectancy and empathy expressions are most promising in 
countering any negative effects of information provision and 
improving advanced cancer patients’ outcomes. Moreover, there 
is a need for a better understanding into why oncologists use 
specific placebo and nocebo effect-inspired communication 
strategies and which strategies are most appreciated by patients. 
These questions need to be answered in follow-up studies. 
Ultimately, evidence-based expectancy and empathy expressions 
should be recommended for clinical use in advanced cancer. 
This specifically applies to expectancy expressions in uncertain 
situations, which seem to be most complex, and the effect of more 
generic or specific empathic behaviors. Additionally, replication 
studies within our and other medical and cultural contexts are 
needed, e.g., in other diseases of a chronic and often ultimately 
fatal nature, in non-Western countries, and with other participants 
such as men or patients with low health literacy. Furthermore, 
future observational studies should focus in more detail on the 
expressed manipulations, e.g., focus on differences between 
dyads, oncologists, and (specialized) hospitals; on differences 
between consultations discussing varying medical outcomes; and 
on sequential analyses of expressed manipulations. Such studies 
could also include other potential forms of expectations, such as 
regarding procedures or expectations regarding patient behavior 
(e.g., self-efficacy). Lastly, larger replication studies could also 
focus on the relation between consultation time and the use of 
positive expectancy and empathy expressions. In our sample, 
given the limited sample size, we explored this association, which 
did not seem to be present [except for the expression of positive 
expectations about side effects, and for showing understanding 
towards emotions (p < 0.01)].
Conclusions
To conclude, our study illustrated that when discussing positive 
or uncertain medical outcomes in advanced breast cancer, 
oncologists predominantly made use of uncertain expectancy 
manipulations. When providing positive expectations, oncologists 
emphasized the doctor–patient relationship, while negative 
expectations focused on the severity of the illness, and the area 
of uncertainty was characterized by a “hope for the best, prepare 
for the worst” approach. Moreover, empathy manipulations were 
generic or specific in nature and were dominated by oncologists 
showing an understanding towards patients’ emotions. A lack 
of empathy was uncommon, and mainly included oncologists 
not picking up on patients’ emotions. Follow-up studies should 
expand observational studies in this field, and focus on which 
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communication strategies are most useful and influence patients’ 
outcomes for the better, to counter any potential negative effects 
of information provision. Such studies should focus especially on 
uncertain and complex medical situations, in which oncologists 
have to discuss uncertain expectations. Ultimately, specific 
placebo and nocebo effect-inspired communication strategies 
can be harnessed in clinical care to improve patient outcomes.
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